On day 3, colitis mice were treated with Tet1/Tet2 siRNA-treated PDLSCs or control PDLSCs by systemic transplantation through tail vein, followed by sacrifice of the mice on day 10 to collect samples for evaluation (Fig. 3a). Here, TET1 is linked to colitis.